The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study.
Expert Opin Biol Ther
; 23(12): 1299-1306, 2023.
Article
in En
| MEDLINE
| ID: mdl-37970654
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Juvenile
/
Hereditary Autoinflammatory Diseases
Limits:
Child
/
Humans
Language:
En
Journal:
Expert Opin Biol Ther
Journal subject:
BIOLOGIA
/
TERAPEUTICA
Year:
2023
Type:
Article